PARP16 protects against cardiac hypertrophic response by ADP-ribosylation-dependent inhibition of NFAT transcription factor
This study demonstrates that PARP16 protects against cardiac hypertrophy and heart failure by ADP-ribosylating and inhibiting the transcriptional activity of NFAT1, a mechanism whose loss leads to pathological cardiac remodeling.